News

The US FDA has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals’ Casgevy and bluebird bio’s Lyfgenia.

The DCGI’s move comes a few days after ET reported that industrial excipients are used in manufacturing medicines and over 50 companies manufacturing cough syrups […]

There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture […]

Research firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood at Rs 75 […]

The objective of this workshop is to bring together industry, regulators, and academia to develop strategies to overcome current challenges with pediatric formulation development.

People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit its reach.

AbbVie’s proposed acquisition of ImmunoGen is expected to accelerate AbbVie’s entry into the commercial market for ovarian cancer and includes ImmunoGen’s flagship cancer therapy, ELAHERE […]

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

Eleven new digital health start-ups have graduated from PharmStars’ twice-yearly education and mentoring programme, with the latest crop focusing on digital innovations in therapeutic delivery. […]

This week PharmaShots’ news was all about the updates on Pharma, Regulatory, Clinical Trials, DigiHealth, M&A & BioSimilar. Check out our full report below: The […]

This week PharmaShots’ news was all about the updates on Pharma, Regulatory, Clinical Trials, DigiHealth, M&A & BioSimilar. Check out our full report below: The […]

Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group.

Shots: The company’s P-III (CheckMate -8HW) study met the dual 1EP of PFS in the Opdivo + Yervoy vs CT for the 1L treatment while […]

Shots: The company’s P-III (CheckMate -8HW) study met the dual 1EP of PFS in the Opdivo + Yervoy vs CT for the 1L treatment while […]

Shots: Vanda signed an agreement with Actelion (a subsidiary of Johnson & Johnson) to acquire the US & Canadian rights for Ponvory (ponesimod), an oral […]

At the start of this year, Aeglea BioTherapeutics was looking like it may go out of business. Now, rebranded as Spyre Therapeutics, it is looking […]

One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses

The project will explore the biology of human autoreactive plasma cells

Shots: The US FDA has approved the company’s INOmax EVOLVE DS delivery system to be used to deliver INOmax gas, an FDA-approved treatment indicated to […]

Shots: The US FDA has approved the company’s INOmax EVOLVE DS delivery system to be used to deliver INOmax gas, an FDA-approved treatment indicated to […]

A trial viewed as the best hope of finding an effective HIV vaccine this decade has ended in failure in another major setback for the […]

Intas Pharmaceuticals Ltd-Walk-In Drive for Quality Control/ Quality Assurance On 23rd Dec’ 2023 Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation […]

Regeneron has moved closer to a regulatory filing for its BCMAxCD3 bispecific antibody linvoseltamab, the first of a series of bispecifics that is spearheading its […]

Regeneron has moved closer to a regulatory filing for its BCMAxCD3 bispecific antibody linvoseltamab, the first of a series of bispecifics that is spearheading its […]

Illuminating, informative, and engaging, our recent webinar on Successful Drug Discovery-Collaboration Among Multiple Functions with Eurofins Advinus, was an energy-packed session that highlighted the intricacies of the […]

Shots: The first patient was dosed in the P-II (ADVANTA) trial evaluating the safety & efficacy of KT-474 (SAR444656) vs PBO in patients with moderate […]

As we edge closer to 2024, it’s time for personal trainers to start thinking about resolutions that can elevate their careers. The fitness industry is […]

Sun Pharma- Walk-In Drive for Freshers & Experienced On 9th Dec’ 2023 Job Description Walk-In Drive for Freshers & Experienced On 9th Dec’ 2023 @ […]

Shots: Merck has halted its P-III (KEYLYNK-008) study, as suggested by an independent DMC which revealed that, at interim analysis (IA3), Keytruda + CT followed […]

Annual Drug Patent Expirations for XPOVIO Xpovio is a drug marketed by Karyopharm Theraps and is included in one NDA. It is available from one […]

Annual Drug Patent Expirations for CRESEMBA Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. […]

Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from […]

Annual Drug Patent Expirations for XOPENEX+HFA Xopenex Hfa is a drug marketed by Lupin and is included in one NDA. It is available from five […]

This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of […]

A technology developed over the past few years for controlling microvehicles using ultrasound also works in the brain, as researchers have now been able to […]

Engineers have developed a bio-compatible ink that solidifies into different 3D shapes and structures by absorbing ultrasound waves. Because the material responds to sound waves […]

A look at the fast-evolving pipeline for gene editing therapies.

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have […]

The White House said today that it may take enforced ownership of patents on medicines developed with public funding if their manufacturers set their prices […]

The commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed drug reactions […]

Today, world-leading generative artificial intelligence (AI) company for life sciences, Yseop, is celebrating its involvement in more than 150 clinical trials with pharma giants around […]

OSP had a great conversation with Mike Connell, chief operating officer, at Enthought. The discussion centered around aritificial intelligence (AI) which have been the buzzwords […]

Shots:  Kylen Cieslak, Senior Manager, Service Marketing, Thermo Fisher Scientific, and Robert Ley, Senior Strategic Product Manager, Thermo Fisher Scientific in a stirring conversation with […]

Shots:  Kylen Cieslak, Senior Manager, Service Marketing, Thermo Fisher Scientific, and Robert Ley, Senior Strategic Product Manager, Thermo Fisher Scientific in a stirring conversation with […]

Adults and children in the US with congenital thrombotic thrombocytopenic purpura (cTTP) can now access Adzynma for prophylactic and on-demand treatment.

Shankar Narayanan, CEO of marketing consulting firm Real Chemistry, weighs in on where the industry is headed in the New Year.

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a Â1 million investment.

Virtual research organization, ObvioHealth, has just announced the launch of its application programming interface (API) which it says is tailored specifically for digital therapeutics (DTx) […]

The FDA has kicked off a priority review of Genfit and Ipsen’s elafibranor as a treatment for rare cholestatic liver disease primary biliary cholangitis (PBC), […]

The disease is one of the leading causes of cancer deaths in the UK

Around 20,000 children are admitted to ICUs every year in the UK

Treatment with Eli Lilly’s JAK inhibitor Olumiant has been shown to preserve the function of insulin-producing pancreatic beta cells in patients with type 1 diabetes, […]

Zydus -Walk-In Interviews for Production (API)/ Production / DQA On 9th Dec’ 2023 Job Description Walk-In Interviews for Production (API)/ Production / DQA On 9th […]

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by […]

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist […]

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist […]

Genomic analysis stands at the forefront of molecular biology and genetics, offering a deep dive into the intricate world of an organism’s entire DNA. As […]

Express your interest in our next Medical Research Future Fund (MRFF) Traumatic Brain Injury Mission Expert Advisory Panel (EAP).

Shots: The expansion builds on Innovent’s Jun 2021 deal with Synaffix under which Innovent could leverage Synaffix’s ADC technologies incl. GlycoConnect, HydraSpace & one of […]

Shots: Both AbbVie and Cerevel Therapeutics have signed a definitive agreement as per which AbbVie will acquire Cerevel for its neuroscience pipeline containing multiple clinical-stage […]

The Nexera UC combines possible UHPLC and SFC separation in a single system. Depending on the focused application, it can offer “green” separation but also […]

STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer ingelheim Patent: 7,056,916 Expiration: Dec 7, 2023 See More … For more information on how DrugPatentWatch can help with your […]

Annual Drug Patent Expirations for ZEGALOGUE+%28AUTOINJECTOR%29 Zegalogue (autoinjector) is a drug marketed by Zealand Pharma and is included in one NDA. It is available from […]

Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from […]

Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from […]

Annual Drug Patent Expirations for ZEGALOGUE Zegalogue is a drug marketed by Zealand Pharma and is included in one NDA. It is available from two […]

Annual Drug Patent Expirations for ELCYS Elcys is a drug marketed by Exela Pharma and is included in one NDA. It is available from one […]

This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with […]

Oncology Center of Excellence Project Endpoint aims to enhance the development of endpoints in oncology drug development and foster engagement with the broader community to […]

Leverage artificial intelligence (AI) for a more streamlined GMP manufacturing process.

The All India Condom Manufacturer Association, which includes various companies that manufacture condom brand Nirodh, has written to the government highlighting haphazard handling of procurement […]

has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention […]

Oral health is a critical component of overall well-being, and growing research suggests that the health of your mouth is closely connected to your body’s […]

Japan’s Taisho Pharmaceutical looks like it could be heading into private ownership, thanks to a management buyout offer (MBO) that could value the company at […]

Zizi Uzezi Imatorbhebhe has more than 30 years of experience in the biopharmaceutical, healthcare and clinical research industries.

Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act

Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act

Piramal Pharma has launched a high-throughput screening facility at its drug discovery services site in Ahmedabad, India.

Shots: Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency   Biosimilars are expected to be a […]

The gene editing biotech is shelving two of its most advanced cancer drugs, and joining a growing group of companies exploring cell-based medicines for inflammatory […]

This year’s many firsts included a vaccine for RSV and a drug that slows Alzheimer’s disease.

[Federal Register Volume 88, (Wednesday, December 6, 2023)] [Notice] [Pages 84833-84834] Agency Information Collection Activities; Submission for OMB Review; Comment Request; Hazardous Waste Operations and […]

Novartis has settled a lawsuit brought by Daiichi Sankyo’s Plexxikon subsidiary, paying $180 million to resolve claims that its Tafinlar cancer drug infringed US patents […]

The commitments will make health systems faster, simpler and fairer for patients

The neurological condition currently affects one in 300 people in the UK

Novartis’ targeted factor B inhibitor iptacopan has become the first oral monotherapy to be approved by the FDA for rare blood disorder paroxysmal nocturnal haemoglobinuria […]

Eli Lilly has invested in its manufacturing capacity once more and has announced plans to build a $2.5 billion high-tech manufacturing site in Germany.

Germany’s Merck KGaA is facing a big hole in its late-stage pipeline after multiple sclerosis candidate evobrutinib missed the mark in two phase 3 trials, […]

A few simple solutions could save lives and ease the struggles of countless Americans.

The VIII International Conference on Antimonopoly Policy at Moscow’s Skolkovo Innovation Center focused on enforcing competition laws in the pharmaceutical market. Representatives from Indian antitrust […]

Sanofi has deepened an existing collaboration with artificial intelligence specialist Aqemia in the latest among a flurry of collaborations between pharma companies and generative AI […]

Shots: The FTD and BTD were granted based on the P-III (BOND-003) trial results for the treatment of high-risk Bacillus Calmette-Guérin (BCG)-unresponsive Non-Muscle Invasive Bladder […]

Shots: The FTD and BTD were granted based on the P-III (BOND-003) trial results for the treatment of high-risk Bacillus Calmette-Guérin (BCG)-unresponsive Non-Muscle Invasive Bladder […]

Juries recently awarded plaintiffs more than $2 billion in damages tied to Roundup, the weedkiller that has been linked to cancer. Bayer is fighting back.

Shots: Both AbbVie and BigHat Biosciences have agreed to sign a collaboration agreement to discover and develop a futuristic approach to antibody treatment in the […]

Shots: The sBLA was accepted by the US FDA for priority review based on the P-III (CheckMate-901) trial evaluating Opdivo + Yervoy or Opdivo + […]

Shots: The sBLA was accepted by the US FDA for priority review based on the P-III (CheckMate-901) trial evaluating Opdivo + Yervoy or Opdivo + […]

Shots: The sBLA was accepted by the US FDA for priority review based on the P-III (CheckMate-901) trial evaluating Opdivo + Yervoy or Opdivo + […]

Shots: The sBLA was accepted by the US FDA for priority review based on the P-III (CheckMate-901) trial evaluating Opdivo + Yervoy or Opdivo + […]

Pharma major Venus Remedies on Wednesday said it has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs. In a statement, the […]

Pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator to market its generic Varenicline tablets indicated for use […]

Image analysis is crucial for particle analysis of complex finished drug products.

Annual Drug Patent Expirations for RADICAVA+ORS Radicava Ors is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from […]

This chart shows the pharmaceutical companies with the most implant dosed drugs. For a different perspective, see the most popular dosage types. The companies with […]

Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.

  Homogreen Healthcare ADDRESS : A DIVISION OF ABIGAIL HEALTHCARE PLOT NO – 160, 1ST FLOOR PHASE 2 , INDUSTRIAL AREA PANCHKULA (H.R.)-134113 “Derma PCD […]

As per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma’s JAK inhibitor, or other isotopic forms of […]

The drugstore chain is introducing a model that will compensate pharmacies based on how much they paid for a drug, as well as a set […]

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The US district judge James Robart upheld the Indian drug maker’s argument that the court lacked jurisdiction over the company and dismissed the case without […]

Patients are facing shorter lives as drug companies are demanding prices that health services here and in other countries cannot pay Cystic fibrosis is a […]

Safety Outcomes When “Switching” Between Biosimilars and Reference Products

The FDA has started a priority review of Bristol-Myers Squibb Opdivo in combination with cisplatin as a first-line therapy for advanced urothelial carcinoma (UC), setting […]

Researchers have developed a light-activatable prodrug nanomedicine for age-related macular degeneration (AMD) therapy. Through the intravenous injection of the nanomedicine and application of light irradiation […]

AstraZeneca will utilize Absci’s AI antibody drug creation platform to create an AI-designed antibody.

Merck has entered into a $70 million licensing agreement with Abbisko Therapeutics for pimicotinib, which is currently being evaluated in a phase 3 study for […]

We sat down with Cary Claiborne, CEO and president of Adial Pharma, to discuss the challenges of treating alcohol abuse and company’s solution â a […]

A Deep Dive: FDA’s Model-Integrated Evidence (MIE) Industry Meeting Pilot Program for Generic Drugs

A significantly greater improvement in people with depression was achieved after they were given ALT-300, an adjunctive treatment, during a phase 2a study.

A significantly greater improvement in people with depression was achieved after they were given ALT-300, an adjunctive treatment, during a phase 2a study.

Finished Pharmaceuticals/Unapproved New Drug

Shots: Over the years, CDMOs have significantly transformed the course of pharmaceutical and biopharmaceutical companies by leveraging their flexible manufacturing facilities and on-time drug deliveries […]

A phase 2 study looking into the treatment setanaxib for inherited kidney disease, Alport syndrome, has begun it was announced last week.

Shots:  Mohamed Eid, VP of Clinical Development & Medical Affairs, Cardio-Renal-Metabolism & Respiratory Medicine, at Boehringer Ingelheim, in a stimulating conversation with PharmaShots sheds light […]

Tom Fletcher, director of Research and Development at FUJIFILM Irvine Scientific; and Bob Newman, PhD, chief scientific director at FUJIFILM Irvine Scientific, discuss formulation, specifically […]

Apps, VR and more could play an increasingly vital role in the wider goals of creating value-based treatments — if the industry can get payers […]

A few years ago, Roche abandoned the development of its lead PIK3CA-targeting drug taselisib on safety grounds, allowing rival Novartis to beat it to market, […]

The platform safely and effectively replicates the electric signalling process compounds

Millions of people in the UK are set to benefit from the second wave of funding

  Abigail Healthcare ADDRESS :PLOT NO – 160, 1ST FLOOR PHASE 2 INDUSTRIAL AREA PANCHKULA “We are one of the recognized manufacturer and wholesaler of […]

The pharma industry and the UK government may have reached an accord on the voluntary scheme of rebates used to limit rises in medicines spending […]

Ronish Bioceuticals Free Size Disposable Coronavirus PPE kit Address : Ronish House, Nanhera Link Road, Kuldeep Nagar, Ambala Cantt,133004 , India “Ronish Bioceuticals” is an […]

Alto Neuroscience has said its therapeutic approach to depression of matching patients to drugs based on brain biomarkers has shown promise in a phase 2a […]

Shots: The US FDA has approved Jaguar’s application to renew the conditional approval of Canalevia-CA1 (crofelemer delayed-release tablets) to treat chemotherapy-induced diarrhea (CID) in dogs. […]

Shots: The US FDA has approved Jaguar’s application to renew the conditional approval of Canalevia-CA1 (crofelemer delayed-release tablets) to treat chemotherapy-induced diarrhea (CID) in dogs. […]

Shots: The collaboration was signed to synergistically combine Absci’s Integrated Drug Creation platform with AstraZeneca’s expertise in oncology to discover a potential new cancer treatment […]

Shots: Under the terms Palvella is qualified to receive up front payment of $5M from Ligand & in exchange, Ligand’s existing tiered royalty on global […]

Neuland Laboratories Pvt. Ltd-Walk-In Drive for CMS/ GDS/ Peptide Synthesis (API) On 9th Dec’ 2023 Job Description Walk-In Drive for CMS/ GDS/ Peptide Synthesis (API) […]

Neuland Laboratories Pvt. Ltd-Walk-In Drive for CMC/ GDS/ Peptide Synthesis (API) On 9th Dec’ 2023 Job Description Walk-In Drive for CMC/ GDS/ Peptide Synthesis (API) […]

Annual Drug Patent Expirations for LUMRYZ Lumryz is a drug marketed by Avadel Cns and is included in one NDA. It is available from one […]

Annual Drug Patent Expirations for ZAVZPRET Zavzpret is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. […]

This chart shows the drugs with the most patents in Ecuador. Patents must be filed in each country (or, in some cases regional patent office) […]

Gland Pharma-Walk-In Interview for B.Sc, B.Pharm, M.Sc, M.Pharm in Quality Control Dept. On 8th Dec’ 2023 Job Description Walk-In Interview for B.Sc, B.Pharm, M.Sc, M.Pharm […]

More than 300 volunteers from across UB provided services, including surgery, cleanings and X-rays, valued at roughly $93,500.

Market expectations for obesity drugs are soaring and competition is heating up. But hitting the heights will require overcoming payer and other issues.

SUNLENCA is a drug that is used with other drugs for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults.

Researchers are investigating the potential of a painless, needle-free vaccine delivery by ultrasound. The method uses cavitation, which is the formation and popping of bubbles […]

Self-folding polymers containing gadolinium forming nanosized complexes could be the key to enhanced magnetic resonance imaging and next-generation drug delivery. Thanks to their small size, […]

While we often think of diseases as caused by foreign bodies — bacteria or viruses — there are hundreds of diseases affecting humans that result […]

A mouse study found that the drug ketamine can alter the brain’s dopamine system, boosting the case for more targeted medical use.

Seismic Therapeutic has raised $121 million in second-round financing that will be used to take its two lead drugs through early-stage clinical testing. Cambridge, Massachusetts-based […]

The U.S. Food and Drug Administration monitors compliance with the ClinicalTrials.gov registration and results information submission requirements as a critical part of our mission to […]

DOSA2, as the latest phase is known, is coordinated by the University of Edinburgh and includes partners at the University of the Arts London, Silchar […]

Germany’s Merck KGaA is paying Chinese biotech Abbisko Therapeutics $70 million upfront for rights to a drug in phase 3 testing for tenosynovial giant cell […]

An AI-designed antibody against an oncology target can now be delivered following a collaboration between Absci Corporation and AstraZeneca.

The medicines, levetiracetam and clobazam, may a cause life-threatening reaction to patients if not caught and treated quickly.

Pfizer is discontinuing danuglipron, its twice-daily weight loss pill, after more than half of patients in a clinical trial stopped taking it.

Novartis has issued a nationwide voluntary recall of two lots of Sandimmune Oral Solution (cyclosporine oral solution, USP), 100 mg/mL because of crystallization issues.

Shots  While sharing the details on Fasenra, Andrew highlights the unmet medical need in the healthcare sector as there’s only one approved treatment for EGPA  […]

Hindsight offers a better perspective on why some deals are fruitful and others fail.

[Federal Register Volume 88, (Monday, December 4, 2023)] [Notice] [Pages 84172-84174] Regulations Containing Procedures for the Handling of Retaliation Complaints; Revision of the Office of […]

[Federal Register Volume 88, (Monday, December 4, 2023)] [Notice] [Pages 84174-84175] Overhead and Gantry Cranes Standard; Extension of the Office of Management and Budget’s (OMB) […]

[Federal Register Volume 88, (Monday, December 4, 2023)] [Notice] [Pages 84174-84175] Overhead and Gantry Cranes Standard; Extension of the Office of Management and Budget’s (OMB) […]

A digital approach to the care of patients with heart failure, developed by Boehringer Ingelheim and ORCHA, will be rolled out in the northwest of […]

The neurological condition affects around 50 million people worldwide

In England, an estimated 4,500 people are living with undiagnosed HIV

Pfizer has decided to discontinue the development of another of its experimental obesity therapies, after seeing high rates of discontinuation with the drug in a […]

Modern medicine makes it seem as if drugs are the only way to deal with diabetes. But what if diet can be a solution? One […]

Supreme court to review immunity of Sacklers from prosecution under a 2019 bankruptcy settlement with the OxyContin maker The US supreme court will hear oral […]

A just-published report has found that more than a third (36%) of people currently living with dementia in the UK are undiagnosed, and major changes […]

The Australian Government has launched Australia’s first National Health and Climate Strategy.

Tests of a cough syrup linked to deaths in Cameroon have revealed quality issues in at least one of five samples taken by Indian authorities, […]

AstraZeneca’s Gemma Satterthwaite talks to the company’s ambition to transform the entire care experience for patients with blood cancers.

AstraZeneca’s Gemma Satterthwaite talks to the company’s ambition to transform the entire care experience for patients with blood cancers.

Roche has agreed a deal to acquire US biotech Carmot Therapeutics that if consummated will thrust it into the increasingly competitive market for incretin-based therapies […]

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (genAI) company Absci that will focus on the discovery of […]

Shots: Roche announces the acquisition of Carmot Therapeutics providing access to Carmot’s portfolio, incl. CT-388 & CT-996, offering treatments for obesity in patients with & […]

Shots: Shanghai Junshi announces the acceptance of TGA for its NCE application for toripalimab+ cisplatin & gemcitabine as 1L treatment of metastatic or recurrent locally […]

Shots: Everest Medicines has received approval from China’s NMPA for the IND application of zetomipzomib in patients with immune-mediated disorders, incl. lupus nephritis (LN) Earlier […]

This chart shows the drugs with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) […]

Likewise, Central Drugs Testing Laboratory (CDTL) Mumbai analysed 523 samples, out of which 18 samples from 10 firms failed quality tests. Regional Drugs Testing Laboratory […]

The company’s net profit increased 3.5% to ‘353 crore amid a 6% jump in expenses to ‘1,826 crore. Employee benefit expenses rose 15% to ‘556 […]

Royal portraits | Viagra article | Losing sucks | Karlheinz Stockhausen | Hum improvement | Appalling apostrophes I’m confused. Is the £8m that Polly Toynbee […]

This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional […]

Links between the deaths of UK patients and the popular drug have spurred on action among expats in Jávea and beyond As Britain faced widespread […]

Novo Nordisk, a Danish pharmaceutical company renowned for its diabetes medicines, is now positioning itself as the world’s leading weight-loss company. The company aims to […]

Best Monopoly Based Pharma Franchise – Pharma Franchisee India, emerging as a prominent B2B platform, is at the forefront of revolutionizing the pharmaceutical industry. With […]